News Detail
Chennai, 30 Jan 2024: Orchid Pharma, based in Chennai, India, on Monday announced that its antibiotic invention, ‘Exblifeb,’ which incorporates Enmetazobactam, has received the European Medicines Agency’s (EMA) recommendation for marketing authorisation.
Source : Press Release
Orchid Pharma
European Medicines Agency (EMA)
Enmetazobactam
Exblifep
Related News
- Drug Control Department merges with Food Department in wake of series of deaths of pregnant women in Bellary (06-12-2024)
- Dehradun police busted drug manufacturing Unit operated under the guise of 'Green Herbal Factory' in Sahaspur area (06-12-2024)
- Ballari maternal deaths: Ready to resign if I'm at fault, says Karnataka HM (06-12-2024)
- FDA Approves New Drug for Lung and Pancreatic Cancers (06-12-2024)
- Surat police nab 13 bogus doctors in fake degree scam (06-12-2024)
- Maternal death toll in Ballari hospital touches five after one more woman dies (06-12-2024)
- Two sacks of medicines recovered from a government flat in Saharanpur (06-12-2024)
- Action taken against 116 Pharma companies in Himachal found not meeting standards (05-12-2024)
- Govt allocates Rs 4534.28 Crores for promotion of AYUSH (05-12-2024)
- FDA finalizes AI-enabled medical device life cycle plan guidance (05-12-2024)